Report cover image

Bone Growth Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Publisher GlobalData
Published Jul 17, 2023
Length 103 Pages
SKU # GBDT18132660

Description

Bone Growth Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Bone Growth Stimulators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Bone Growth Stimulators pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bone growth stimulators are mainly used to facilitate bone growth in impaired or delayed healing fractures/fusions.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Bone Growth Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Growth Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Growth Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

103 Pages
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Bone Growth Stimulators Overview
4 Products under Development
4.1 Bone Growth Stimulators - Pipeline Products by Stage of Development
4.2 Bone Growth Stimulators - Pipeline Products by Segment
4.3 Bone Growth Stimulators - Pipeline Products by Territory
4.4 Bone Growth Stimulators - Pipeline Products by Regulatory Path
4.5 Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
4.6 Bone Growth Stimulators - Ongoing Clinical Trials
5 Bone Growth Stimulators - Pipeline Products under Development by Companies
5.1 Bone Growth Stimulators Companies - Pipeline Products by Stage of Development
5.2 Bone Growth Stimulators – Companies Pipeline Products by Stage of Development
6 Bone Growth Stimulators Companies and Product Overview
6.1 Bionext Biotech Products Ltd. Company Overview
6.1.1 Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview
6.2 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Company Overview
6.2.1 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview
6.3 Curative Biosciences, Inc. Company Overview
6.3.1 Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.4 DJO Global Inc Company Overview
6.4.1 DJO Global Inc Pipeline Products & Ongoing Clinical Trials Overview
6.5 Eepta Pty Ltd Company Overview
6.5.1 Eepta Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.6 GreenBone Ortho srl Company Overview
6.6.1 GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview
6.7 Inion Oy Company Overview
6.7.1 Inion Oy Pipeline Products & Ongoing Clinical Trials Overview
6.8 Johns Hopkins University Company Overview
6.8.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
6.9 KeraCure, Inc. (Inactive) Company Overview
6.9.1 KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.10 Lattice Biologics Ltd Company Overview
6.10.1 Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.11 Magle Chemoswed AB Company Overview
6.11.1 Magle Chemoswed AB Pipeline Products & Ongoing Clinical Trials Overview
6.12 Max Biopharma Inc Company Overview
6.12.1 Max Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
6.13 NC Biomatrix BV Company Overview
6.13.1 NC Biomatrix BV Pipeline Products & Ongoing Clinical Trials Overview
6.14 NDSU Research Foundation Company Overview
6.14.1 NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview
6.15 Oklahoma State University Company Overview
6.15.1 Oklahoma State University Pipeline Products & Ongoing Clinical Trials Overview
6.16 Oligo Medic Inc Company Overview
6.16.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
6.17 Orthocell Ltd Company Overview
6.17.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.18 Orthofix Medical Inc Company Overview
6.18.1 Orthofix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.19 OsteoGenix Incorporated (Inactive) Company Overview
6.19.1 OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.20 REGENECURE Ltd Company Overview
6.20.1 REGENECURE Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.21 Texas A&M University Company Overview
6.21.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview
6.22 The University of Nottingham Company Overview
6.22.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
6.23 Universiti Putra Malaysia Company Overview
6.23.1 Universiti Putra Malaysia Pipeline Products & Ongoing Clinical Trials Overview
6.24 University of California Davis Company Overview
6.24.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview
6.25 University of Florida Company Overview
6.25.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
6.26 University of Wisconsin Madison Company Overview
6.26.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
6.27 Wright Medical Group NV (Inactive) Company Overview
6.27.1 Wright Medical Group NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.28 ZetaGen Therapeutics Inc Company Overview
6.28.1 ZetaGen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.29 ZimVie Inc Company Overview
6.29.1 ZimVie Inc Pipeline Products & Ongoing Clinical Trials Overview
7 Bone Growth Stimulators- Recent Developments
7.1 May 24, 2023: CollPlant Biotechnologies announces first quarter financial results for 2023 and provides corporate update
7.2 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.3 May 02, 2023: Zimmer Biomet Publishes 2022 Sustainability Report
7.4 Apr 27, 2023: Integer Holdings reports First Quarter 2023 results
7.5 Apr 19, 2023: Anika to issue first quarter 2023 financial results on Tuesday, may 9, 2023
7.6 Apr 12, 2023: Medtronic has a layoff in California
7.7 Mar 31, 2023: Bioventus announces Q4 and full-year 2022 financial results
7.8 Mar 30, 2023: Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023
7.9 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders
7.10 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
7.11 Mar 06, 2023: Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results
7.12 Feb 21, 2023: Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023
7.13 Feb 16, 2023: Integer Holdings Reports Results for Fourth Quarter and Full Year 2022
7.14 Feb 14, 2023: Spineway Reports Full Year 2022 Earnings
7.15 Feb 09, 2023: Spineway announces 2022 annual results
7.16 Dec 01, 2022: CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results
7.17 Nov 23, 2022: Medtronic Reports Quarterly Earnings
7.18 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
7.19 Nov 21, 2022: Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
7.20 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
7.21 Nov 08, 2022: Anika Reports Third Quarter Fiscal 2022 Financial Results
7.22 Oct 27, 2022: Integer Holdings Reports Third Quarter 2022 Results
7.23 Oct 25, 2022: Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
7.24 Oct 11, 2022: Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting
7.25 Sep 07, 2022: Medtronic to appear at September investor conferences
7.26 Aug 25, 2022: Collplant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results
7.27 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
7.28 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
7.29 Aug 11, 2022: Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
7.30 Aug 09, 2022: Kuros Biosciences reports results for the first six months of 2022
7.31 Aug 03, 2022: Anika Reports Second Quarter Fiscal 2022 Financial Results
7.32 Aug 02, 2022: Zimmer Biomet Announces Second Quarter 2022 Financial Results
7.33 Jul 28, 2022: Smith+Nephew Second Quarter and First Half 2022 Results
7.34 Jul 28, 2022: Integer Holdings Reports Second Quarter 2022 Results
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Bone Growth Stimulators - Pipeline Products by Stage of Development
Table 2: Bone Growth Stimulators - Pipeline Products by Segment
Table 3: Bone Growth Stimulators - Pipeline Products by Territory
Table 4: Bone Growth Stimulators - Pipeline Products by Regulatory Path
Table 5: Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
Table 6: Bone Growth Stimulators - Ongoing Clinical Trials
Table 7: Bone Growth Stimulators Companies - Pipeline Products by Stage of Development
Table 8: Bone Growth Stimulators – Companies Pipeline Products by Stage of Development
Table 9: Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Orthonext - Product Status
Table 11: Orthonext - Product Description
Table 12: Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Bioactive Glass Scaffold - Product Status
Table 14: Bioactive Glass Scaffold - Product Description
Table 15: Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Nurture BSP - Product Status
Table 17: Nurture BSP - Product Description
Table 18: Osteoconductive Scaffold - Product Status
Table 19: Osteoconductive Scaffold - Product Description
Table 20: DJO Global Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: CMF OL1000 - Fresh Ankle Fracture - Product Status
Table 22: CMF OL1000 - Fresh Ankle Fracture - Product Description
Table 23: DJO Global Inc - Ongoing Clinical Trials Overview
Table 24: CMF OL1000 - Fresh Ankle Fracture - Prospective, Randomized, Double-blinded, Controlled Multi-center Clinical Trial Evaluating the Use of Non-invasive CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures
Table 25: Eepta Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Bone Growth Scaffold - Product Status
Table 27: Bone Growth Scaffold - Product Description
Table 28: GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview
Table 29: b.Bone Implant - Product Status
Table 30: b.Bone Implant - Product Description
Table 31: GreenBone Ortho srl - Ongoing Clinical Trials Overview
Table 32: b.Bone Implant - A Pre-market Multicenter National Open Label Single Arm Study to Evaluate the Safety and Performance of a Class III Medical Device (Greenbone Implant) for Iliac Crest Reconstruction Following Bone Graft Harvesting for Pelvic Fusion
Table 33: b.Bone Implant - A Pre-market, Multi-center, International, Open-label, Single-arm Study to Evaluate the Safety and Performance of a Class III Medical Device (GreenBone Implant) for Surgical Repair of Long Bone Defects
Table 34: b.Bone Implant - A Pre-market, Open-label, Single-arm Study to Evaluate b.Bone for Posterolateral Fusion Treatment of Degenerative Thoracolumbar, Lumbar or Lumbosacral Spinal Disease (b.Spine Clinical Trial).
Table 35: Inion Oy Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Inion Optimaplus - Product Status
Table 37: Inion Optimaplus - Product Description
Table 38: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 39: 3D-printed Bone Extracellular Matrix Scaffold - Product Status
Table 40: 3D-printed Bone Extracellular Matrix Scaffold - Product Description
Table 41: KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 42: KeraPac - Bone Regeneration - Product Status
Table 43: KeraPac - Bone Regeneration - Product Description
Table 44: Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Bone Scaffold + ECM - Product Status
Table 46: Bone Scaffold + ECM - Product Description
Table 47: Magle Chemoswed AB Pipeline Products & Ongoing Clinical Trials Overview
Table 48: SmartBone - Product Status
Table 49: SmartBone - Product Description
Table 50: Max Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Oxy133 Implantable Device - Product Status
Table 52: Oxy133 Implantable Device - Product Description
Table 53: NC Biomatrix BV Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Vitadisc - Product Status
Table 55: Vitadisc - Product Description
Table 56: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Bone Scaffold - Product Status
Table 58: Bone Scaffold - Product Description
Table 59: Oklahoma State University Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Bone Repair Scaffold - Product Status
Table 61: Bone Repair Scaffold - Product Description
Table 62: Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 63: BoneRep - Product Status
Table 64: BoneRep - Product Description
Table 65: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 66: CelGro SMRT Graft - Bone Repair - Product Status
Table 67: CelGro SMRT Graft - Bone Repair - Product Description
Table 68: Orthofix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Product Status
Table 70: Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Product Description
Table 71: Physio-Stim Osteogenesis Stimulator - Osteoarthritis - Product Status
Table 72: Physio-Stim Osteogenesis Stimulator - Osteoarthritis - Product Description
Table 73: RCStim Device - Product Status
Table 74: RCStim Device - Product Description
Table 75: Orthofix Medical Inc - Ongoing Clinical Trials Overview
Table 76: RCStim Device - Prospective, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy as an Adjunctive Treatment to Surgical Repair of Full Thickness Rotator Cuff Tears
Table 77: OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Bone Anabolic Agent - Product Status
Table 79: Bone Anabolic Agent - Product Description
Table 80: REGENECURE Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Regenecure AMCA GBR Bone Membrane Implant - Product Status
Table 82: Regenecure AMCA GBR Bone Membrane Implant - Product Description
Table 83: Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Bioactive Foam Based Moldable Scaffold - Product Status
Table 85: Bioactive Foam Based Moldable Scaffold - Product Description
Table 86: The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Injectable Bone - Product Status
Table 88: Injectable Bone - Product Description
Table 89: Universiti Putra Malaysia Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Nanocomposite Bone Scaffold - Product Status
Table 91: Nanocomposite Bone Scaffold - Product Description
Table 92: University of California Davis Pipeline Products & Ongoing Clinical Trials Overview
Table 93: Synthetic Bone Matrix - Product Status
Table 94: Synthetic Bone Matrix - Product Description
Table 95: University of Florida Pipeline Products & Ongoing Clinical Trials Overview
Table 96: Bone Tissue Scaffold - Product Status
Table 97: Bone Tissue Scaffold - Product Description
Table 98: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
Table 99: Fracture Electrostimulation Device - Product Status
Table 100: Fracture Electrostimulation Device - Product Description
Table 101: Wright Medical Group NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Soft Tissue Graft - Product Status
Table 103: Soft Tissue Graft - Product Description
Table 104: ZetaGen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Nalovent Bone Graft - Product Status
Table 106: Nalovent Bone Graft - Product Description
Table 107: ZetaMet - Product Status
Table 108: ZetaMet - Product Description
Table 109: ZetaGen Therapeutics Inc - Ongoing Clinical Trials Overview
Table 110: ZetaMet - Feasibility Study of ZetaFuse Bone Graft in the Repair of Bone Defects From Metastatic Breast Cancer in the Spinal Vertebral Body
Table 111: ZimVie Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 112: OrthoPak III - Product Status
Table 113: OrthoPak III - Product Description
Table 114: Glossary
2.2 List of Figures
Figure 1: Bone Growth Stimulators - Pipeline Products by Stage of Development
Figure 2: Bone Growth Stimulators - Pipeline Products by Segment
Figure 3: Bone Growth Stimulators - Pipeline Products by Territory
Figure 4: Bone Growth Stimulators - Pipeline Products by Regulatory Path
Figure 5: Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
Figure 6: Bone Growth Stimulators - Ongoing Clinical Trials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us